Clinical significance of the pharmacokinetic and pharmacodynamic characteristics of fosfomycin for the treatment of patients with systemic infections
- 15 October 2009
- journal article
- review article
- Published by Elsevier in International Journal of Antimicrobial Agents
- Vol. 34 (6), 506-515
- https://doi.org/10.1016/j.ijantimicag.2009.08.013
Abstract
No abstract availableKeywords
This publication has 89 references indexed in Scilit:
- Fosfomycin: Use Beyond Urinary Tract and Gastrointestinal InfectionsClinical Infectious Diseases, 2008
- Antimicrobial susceptibility of multidrug-resistant Gram negative bacteria to fosfomycinEuropean Journal of Clinical Microbiology & Infectious Diseases, 2008
- Immunomodulatory Effects of Fosfomycin in Experimental Human EndotoxemiaAntimicrobial Agents and Chemotherapy, 2007
- Antibiotic Abscess Penetration: Fosfomycin Levels Measured in Pus and Simulated Concentration-Time ProfilesAntimicrobial Agents and Chemotherapy, 2005
- Penetration of Fosfomycin into Inflammatory Lesions in Patients with Cellulitis or Diabetic Foot SyndromeAntimicrobial Agents and Chemotherapy, 2003
- Fosfomycin TromethamineDrugs, 1997
- Oral prophylaxis with fosfomycin trometamol in transurethral prostatectomy and urological maneuvers: Literature review and personal experienceInfection, 1992
- Mechanisms of Intestinal Absorption of the Antibiotic, Fosfomycin, in Brush-Border Membrane Vesicles in Rabbits and Humans.Journal of Pharmacobio-Dynamics, 1992
- An increase in the antimicrobial activity in vitro of fosfomycin under anaerobic conditionsJournal of Antimicrobial Chemotherapy, 1989
- The influence of uremia on the accessibility of phosphomycin into interstitial tissue fluidEuropean Journal of Clinical Pharmacology, 1983